Does patient-tailored immunotherapy pave the way for new renal cell carcinoma treatment perspectives?

被引：0
|
作者：
Van Brussel, Ilse [1 ]
Van Craenenbroeck, Amaryllis H. [2 ]
Schrijvers, Dorien M. [3 ]
Cools, Nathalie [4 ]
机构：
[1] Univ Antwerp, Lab Pharmacol, B-2610 Antwerp, Belgium
[2] Univ Antwerp Hosp, Div Nephrol Hypertens, B-2650 Antwerp, Belgium
[3] Univ Antwerp, Lab Physiopharmacol, B-2610 Antwerp, Belgium
[4] Univ Antwerp, Vaccine & Infect Dis Inst VAXINFECTIO, Lab Expt Hematol, B-2610 Antwerp, Belgium
来源：
TRANSLATIONAL ANDROLOGY AND UROLOGY | 2013年 / 2卷 / 02期
关键词：
D O I：
10.3978/j.issn.2223-4683.2012.10.02
中图分类号：
R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
摘要：
引用
收藏
页码：85 / 88
页数：4
相关论文
共 50 条
  • [1] New Perspectives in Treating Acute Myeloid Leukemia: Driving towards a Patient-Tailored Strategy
    Andreozzi, Fabio
    Massaro, Fulvio
    Wittnebel, Sebastian
    Spilleboudt, Chloe
    Lewalle, Philippe
    Salaroli, Adriano
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
  • [2] New perspectives in the treatment of metastatic renal cell carcinoma
    Barriere, Jerome
    Hoch, Benjamin
    Ferrero, Jean-Marc
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2012, 84 : E16 - E23
  • [3] Axitinib in the treatment of renal cell carcinoma: patient selection and perspectives
    Narayan, Vivek
    Haas, Naomi Balzer
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2016, 9 : 65 - 72
  • [4] Tivozanib for the treatment of renal cell carcinoma: patient selection and perspectives
    Rodenburg, R. J.
    Eskens, F. A. L. M.
    INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE, 2019, 12 : 137 - 141
  • [5] Development of a FACS-based Smac/DIABLO release assay to monitor individual drug responses and to pave the way towards patient-tailored therapies
    Jigyasa Arora
    Ralf Michael Zwacka
    Andrea Mohr
    Journal of Inflammation, 12 (Suppl 1)
  • [6] Future perspectives for personalized immunotherapy in renal cell carcinoma
    Ciccarese, Chiara
    Di Nunno, Vincenzo
    Iacovelli, Roberto
    Massari, Francesco
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2017, 17 (09) : 1049 - 1052
  • [7] PATIENT-TAILORED ADOPTIVE IMMUNOTHERAPY WITH EBVSPECIFIC T CELLS FROM STEM CELL AND THIRD PARTY DONORS
    Maecker-Kolhoff, Britta
    Bonifacius, Agnes
    Lamottke, Britta
    Tischer-Zimmermann, Sabine
    Schultze-Florey, Rebecca
    Goudeva, Lilia
    Heuft, Hans-Gert
    Arseniev, Lubomir
    Beier, Rita
    Beutel, Gernot
    Cario, Gunnar
    Froehlich, Birgit
    Greil, Johann
    Hansmann, Leo
    Hasenkamp, Justin
    Hoefs, Michaela
    Hundsdoerfer, Patrick
    Jost, Edgar
    Kafa, Kinan
    Kriege, Oliver
    Kroeger, Nicolaus
    Mathas, Stephan
    Meisel, Roland
    Nathrath, Michaela
    Putkonen, Mervi
    Ravens, Sarina
    Reinhardt, Hans Christian
    Sala, Elisa
    Sauer, Martin
    Schmitt, Clemens
    Schroers, Roland
    Steckel, Nina K.
    Trappe, Ralf Ulrich
    Verbeek, Mareike
    Wolff, Daniel
    Blasczcyk, Rainer
    Eizvesper, Britta
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 236 - 237
  • [8] Immunotherapy: A new standard in the treatment of metastatic clear cell renal cell carcinoma
    Popovic, Maja
    Matovina-Brko, Gorana
    Jovic, Masa
    Popovic, Lazar S.
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2022, 13 (01): : 28 - 38
  • [9] Immunotherapy and Metastatic Renal Cell Carcinoma: A Review of New Treatment Approaches
    Kathuria-Prakash, Nikhita
    Drolen, Claire
    Hannigan, Christopher A.
    Drakaki, Alexandra
    LIFE-BASEL, 2022, 12 (01):
  • [10] An Evaluation of Cabozantinib for the Treatment of Renal Cell Carcinoma: Focus on Patient Selection and Perspectives
    Iaxx, Romain
    Lefort, Felix
    Domblides, Charlotte
    Ravaud, Alain
    Bernhard, Jean-Christophe
    Gross-Goupil, Marine
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2022, 18 : 619 - 632
12345